Form 4: CareDx General Counsel Sells Stock via 10b5-1 Plan
Insider Transaction Report
Jeffrey Adam Novack, CareDx's Secretary and General Counsel, reported the sale of 2,688 shares of common stock at $15.5219 per share, executed under a Rule 10b5-1 trading plan.
Summary
- Jeffrey Adam Novack, the Secretary and General Counsel of CareDx, Inc. (CDNA), reported a transaction involving the company's common stock.
- On November 7, 2025, Novack disposed of 2,688 shares of CareDx common stock.
- The shares were sold at a price of $15.5219 per share.
- Following this transaction, Novack beneficially owns 105,218 shares of CareDx common stock directly.
- This transaction was executed pursuant to a Rule 10b5-1 trading plan, which Novack adopted on September 4, 2025.
Sentiment
Score: 5
Explanation: The filing reports a routine insider stock sale executed under a pre-arranged 10b5-1 trading plan, which is a neutral event and does not reflect discretionary action based on new information.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Minimal impact as it is a pre-planned, relatively small sale by an executive, not indicative of a change in company fundamentals.
Key Dates
| Date | Description |
|---|---|
| 2025-09-04 | Adoption of Rule 10b5-1 trading plan by Jeffrey Adam Novack. |
| 2025-11-07 | Transaction date for the sale of 2,688 shares of common stock. |
| 2025-11-10 | Date the Form 4 was signed by Jeffrey Adam Novack. |
Keywords
CareDx, CDNA, Form 4, Insider Transaction, Stock Sale, Jeffrey Adam Novack, 10b5-1 Plan, Corporate Officer, General Counsel
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.